SYROS PHARMACEUTICALS, INC. — Net Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e4eba0a2-1342-4904-a5cf-b78f4dd472a9/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-164.6M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-036808 |
| FY 2022 | $-94.7M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-005702 |
| FY 2021 | $-86.6M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-020246 |
| FY 2020 | $-84.0M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-024498 |
| FY 2019 | $-75.4M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-022351 |
| FY 2018 | $-62.3M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-014558 |
| FY 2017 | $-54.0M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-004563 |
| FY 2016 | $-47.7M | 2016-01-01 – 2016-12-31 | evidence 0001558370-17-004335 |
| FY 2015 | $-29.8M | 2015-01-01 – 2015-12-31 | evidence 0001558370-17-001938 |
| FY 2014 | $-13.4M | 2014-01-01 – 2014-12-31 | evidence 0001558370-17-001938 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SYROS PHARMACEUTICALS, INC. — all facts · Revenue · Operating Income